Literature DB >> 19075063

Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.

Laurent Poirel1, José-Manuel Rodriguez-Martinez, Patrick Plésiat, Patrice Nordmann.   

Abstract

Chromosomally encoded ss-lactamases from the Burkholderia cepacia complex species (formerly Pseudomonas cepacia) were characterized. Cloning and sequencing identified an Ambler class A ss-lactamase (PenB) from B. cenocepacia. It shares 82% amino acid identity with the PenA ss-lactamases previously identified from B. multivorans 249. Its expression was dependent upon a LysR-type regulatory protein. Its narrow-spectrum hydrolysis activity mostly included penicillins but also included expanded-spectrum cephalosporins and aztreonam at lower levels. In that study, Pen-like ss-lactamases (PenC, PenD, PenE, PenF) that shared 63 to 92% identity with PenB from B. cenocepacia were identified from other Burkholderia species. The corresponding ss-lactamase genes might be used as genetic tools for accurate Burkholderia species identification.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075063      PMCID: PMC2650541          DOI: 10.1128/AAC.00946-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Investigation of Burkholderia cepacia nosocomial outbreak with high fatality in patients suffering from diseases other than cystic fibrosis.

Authors:  Asem A Shehabi; Waleed Abu-Al-Soud; Azmi Mahafzah; Najwa Khuri-Bulos; Ilham Abu Khader; Ibn-Sina Ouis; Torkel Wadström
Journal:  Scand J Infect Dis       Date:  2004

2.  Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.

Authors:  Juyan Zhou; Yunhua Chen; Setareh Tabibi; Luis Alba; Elizabeth Garber; Lisa Saiman
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

3.  Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy.

Authors:  A Fiore; S Laevens; A Bevivino; C Dalmastri; S Tabacchioni; P Vandamme; L Chiarini
Journal:  Environ Microbiol       Date:  2001-02       Impact factor: 5.491

4.  Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility.

Authors:  Annamaria Bevivino; Claudia Dalmastri; Silvia Tabacchioni; Luigi Chiarini; Maria L Belli; Sandra Piana; Alberto Materazzo; Peter Vandamme; Graziana Manno
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex.

Authors:  Sazini Nzula; Peter Vandamme; John R W Govan
Journal:  J Antimicrob Chemother       Date:  2002-08       Impact factor: 5.790

6.  Isolation of Burkholderia cepacia complex genomovars from waters.

Authors:  Karen Vermis; Mariya Brachkova; Peter Vandamme; Hans Nelis
Journal:  Syst Appl Microbiol       Date:  2003-11       Impact factor: 4.022

7.  An epidemic Burkholderia cepacia complex strain identified in soil.

Authors:  John J LiPuma; Theodore Spilker; Tom Coenye; Carlos F Gonzalez
Journal:  Lancet       Date:  2002-06-08       Impact factor: 79.321

8.  Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Daniel Aubert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  Polyclonal outbreak of Burkholderia cepacia complex bacteraemia in haemodialysis patients.

Authors:  M Magalhães; C Doherty; J R W Govan; P Vandamme
Journal:  J Hosp Infect       Date:  2003-06       Impact factor: 3.926

10.  Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.

Authors:  David P Speert; Deborah Henry; Peter Vandamme; Mary Corey; Eshwar Mahenthiralingam
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  30 in total

Review 1.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

Review 2.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

3.  Substrate spectrum extension of PenA in Burkholderia thailandensis with a single amino acid deletion, Glu168del.

Authors:  Hyojeong Yi; Karan Kim; Kwang-Hwi Cho; Oksung Jung; Heenam Stanley Kim
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

4.  Insights into β-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants.

Authors:  Krisztina M Papp-Wallace; Magdalena A Taracila; Julian A Gatta; Nozomi Ohuchi; Robert A Bonomo; Michiyoshi Nukaga
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

5.  Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.

Authors:  Benoît Doublet; Frédéric Robin; Isabelle Casin; Laëtitia Fabre; Anne Le Fleche; Richard Bonnet; François-Xavier Weill
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

6.  Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant Burkholderia Species Isolates from the United States.

Authors:  Elise T Zeiser; Scott A Becka; Melissa D Barnes; Magdalena A Taracila; John J LiPuma; Krisztina M Papp-Wallace
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

7.  Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen.

Authors:  Krisztina M Papp-Wallace; Scott A Becka; Magdalena A Taracila; Elise T Zeiser; Julian A Gatta; John J LiPuma; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

8.  "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli Cystic Fibrosis Isolates.

Authors:  Elise T Zeiser; Scott A Becka; Brigid M Wilson; Melissa D Barnes; John J LiPuma; Krisztina M Papp-Wallace
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 9.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

10.  Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.

Authors:  Krisztina M Papp-Wallace; Scott A Becka; Magdalena A Taracila; Marisa L Winkler; Julian A Gatta; Drew A Rholl; Herbert P Schweizer; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.